BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Australian Cancer Technology Limited 

ACN 007 701 715
88 Phillip Street

Level 36, Suite 4
Sydney    NSW 2000  Australia
Phone: 61-2-9252-6899 Fax: 61-2-9252-6877


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Australian Cancer Technology Limited Completes Patient Recruitment For Phase IIb Pentrys Trial10/19/2005 5:13:03 PM
New CEO For Australian Cancer Technology Limited10/19/2005 5:12:59 PM
Australian Cancer Technology Limited CEO, Board Members Resign10/19/2005 5:12:51 PM
Australian Cancer Technology Limited Vaccine Adjuvant Demonstrates Enhanced Immune Response In Prostate Cancer Patients10/19/2005 5:12:49 PM
Australian Cancer Technology Limited Provides Update on Ongoing Clinical Study Of Pentrys Vaccine For Prostate Cancer10/19/2005 5:12:46 PM
Positive Phase I/II Results From Pancreatic Cancer Study Announced By Bioaccelerate Holdings Inc. And Australian Cancer Technology Limited10/19/2005 5:12:39 PM
Australian Cancer Technology Limited Establishes Corporate Office In San Diego, CA; Proposes Name Change To Avantogen10/19/2005 5:12:39 PM
Australian Cancer Technology Limited Announces Change In Board Of Directors10/19/2005 5:12:38 PM
AustCancer Commences Phase II Clinical Study Of RP101 For Metastatic Pancreatic Cancer 10/19/2005 5:12:28 PM
Australian Cancer Technology Limited Appoints New Vice President, Sales And Marketing To Boost Nutritional Products Business10/19/2005 5:12:17 PM
123